| Literature DB >> 26515510 |
S Ehsan Saffari1,2, Áskell Löve3,4, Mats Fredrikson5, Örjan Smedby6,7.
Abstract
BACKGROUND: For optimizing and evaluating image quality in medical imaging, one can use visual grading experiments, where observers rate some aspect of image quality on an ordinal scale. To analyze the grading data, several regression methods are available, and this study aimed at empirically comparing such techniques, in particular when including random effects in the models, which is appropriate for observers and patients.Entities:
Mesh:
Year: 2015 PMID: 26515510 PMCID: PMC4627379 DOI: 10.1186/s12880-015-0083-y
Source DB: PubMed Journal: BMC Med Imaging ISSN: 1471-2342 Impact factor: 1.930
Estimated parameters, goodness-of-fit statistics and estimated dose reduction for GWscore
| Model | Coefficient | Goodness-of-fit | Dose reduction | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| logCTDI | id2 | id4 | AIC | Pseudo R2 | id2 | id4 | ||||
| Est. | P-value | Est. | P-value | Est. | P-value | |||||
| regressa | 1.459 | <0.001 | 0.158 | <0.001 | 0.208 | <0.001 | - | 0.4160 | 10.29 % | 13.31 % |
| (1.244, 1.674) | (0.082, 0.234) | (0.132, 0.284) | (6.14 %, 14.43 %) | (9.37 %, 17.24 %) | ||||||
| ologita | 8.825 | <0.001 | 0.966 | <0.001 | 1.271 | <0.001 | 1124.35 | 0.4172 | 10.37 % | 13.41 % |
| (7.354, 10.295) | (0.512, 1.419) | (0.812, 1.730) | (6.35 %, 14.39 %) | (9.60 %, 17.23 %) | ||||||
| gologit2a =2 | 9.487 | <0.001 | 1.262 | <0.001 | 1.465 | <0.001 | 1184.56 | 0.4342 | 12.45 % | 14.31 % |
| (7.213, 11.761) | (0.682, 1.842) | (0.873, 2.058) | (7.44 %, 17.46 %) | (9.25 %, 19.37 %) | ||||||
| gologit2a =3 | 8.165 | <0.001 | 0.521 | 0.172 | 0.985 | 0.008 | 6.18 % | 11.37 % | ||
| (6.143, 10.189) | (−.227, 1.269) | (0.260, 1.711) | (−1.62 %, 13.98 %) | (4.87 %, 17.86 %) | ||||||
| slogita | 17.447 | <0.001 | 1.887 | <0.001 | 2.433 | <0.001 | 1123.27 | 0.4201 | 10.25 % | 13.05 % |
| (14.460, 20.435) | (1.028, 2.746) | (1.555, 3.310) | (6.35 %, 14.15 %) | (9.23 %, 16.80 %) | ||||||
| mixedb | 1.459 | <0.001 | 0.158 | <0.001 | 0.208 | <0.001 | 1225.30 | 0.2748 | 10.29 % | 13.31 % |
| (1.244, 1.673) | (0.082, 0.234) | (0.132, 0.284) | (6.14 %, 14.43 %) | (9.38 %, 17.24 %) | ||||||
| meologitb | 8.433 | <0.001 | 0.922 | <0.001 | 1.213 | <0.001 | 1215.96 | 0.2751 | 10.36 % | 13.4 % |
| (6.685, 10.180) | (0.452, 1.392) | (0.735, 1.692) | (6.21 %, 14.51 %) | (9.49 %, 17.32 %) | ||||||
95 % confidence limits of each estimate given in parentheses
aregression model with fixed effects only
bregression model with fixed and random effects
Estimated parameters, goodness-of-fit statistics and estimated dose reduction for BGscore
| Model | Coefficient | Goodness-of-fit | Dose reduction | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| logCTDI | id2 | id4 | AIC | Pseudo R2 | id2 | id4 | ||||
| Est. | P-value | Est. | P-value | Est. | P-value | |||||
| regressa | 1.329 | <0.001 | 0.129 | 0.001 | 0.183 | <0.001 | - | 0.3645 | 9.26 % | 12.88 % |
| (1.113, 1.546) | (0.052, 0.206) | (0.107, 0.260) | (4.58 %, 13.94 %) | (8.50 %, 17.26 %) | ||||||
| ologita | 8.249 | <0.001 | 0.760 | 0.001 | 1.071 | <0.001 | 1135.11 | 0.3705 | 8.80 % | 12.17 % |
| (6.766, 9.732) | (0.321, 1.200) | (0.623, 1.520) | (4.44 %, 13.17 %) | (8.00 %, 16.35 %) | ||||||
| gologit2a | 7.804 | <0.001 | 0.883 | 0.001 | 1.431 | <0.001 | 1190.70 | 0.3915 | 10.69 % | 16.76 % |
| =2 | (5.807, 9.801) | (0.368, 1.398) | (0.877, 1.986) | (5.18 %, 16.21 %) | (10.97 %, 22.55 %) | |||||
| gologit2a | 7.842 | <0.001 | 0.505 | 0.261 | 0.408 | 0.369 | 6.24 % | 5.07 % | ||
| =3 | (5.577, 10.107) | (−.376, 1.387) | (−.481, 1.298) | (−3.27 %, 15.76 %) | (−4.86 %, 15.00 %) | |||||
| slogita | 15.378 | <0.001 | 1.337 | 0.001 | 2.036 | <0.001 | 1124.99 | 0.3791 | 8.33 % | 12.40 % |
| (12.340, 18.42) | (0.577, 2.098) | (1.246, 2.826) | (4.17 %, 12.48 %) | (8.30 %, 16.50 %) | ||||||
| mixedb | 1.329 | <0.001 | 0.129 | 0.001 | 0.183 | <0.001 | 1224.58 | 0.2207 | 9.26 % | 12.88 % |
| (1.114,1.545) | (0.053, 0.206) | (0.107, 0.260) | (4.59 %, 13.93 %) | (8.51 %, 17.26 %) | ||||||
| meologitb | 7.806 | <0.001 | 0.736 | <0.001 | 1.031 | <0.001 | 1216.93 | 0.2230 | 9.00 % | 12.38 % |
| (6.733, 8.879) | (0.327, 1.146) | (.618, 1.445) | (4.52 %, 13.48 %) | (8.09 %, 16.67 %) | ||||||
95 % confidence limits of each estimate given in parentheses
aregression model with fixed effects only
bregression model with fixed and random effects
Estimated parameters, goodness-of-fit statistics and estimated dose reduction for GQscore
| Model | Coefficient | Goodness-of-fit | Dose Reduction | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| logCTDI | id2 | id4 | AIC | Pseudo R2 | id2 | id4 | ||||
| Est. | P-value | Est. | P-value | Est. | P-value | |||||
| regressa | 1.424 | <0.001 | 0.158 | <0.001 | 0.175 | <0.001 | - | 0.3560 | 10.53 % | 11.57 % |
| (1.217, 1.630) | (0.085, 0.232) | (0.102, 0.248) | (6.46 %, 14.59 %) | (7.58 %, 15.56 %) | ||||||
| ologita | 9.626 | <0.001 | 1.011 | <0.001 | 1.133 | <0.001 | 1060.25 | 0.3573 | 9.97 % | 11.10 % |
| (8.020, 11.232) | (0.547, 1.476) | (0.665, 1.600) | (6.13 %, 13.17 %) | (7.32 %, 14.88 %) | ||||||
| gologit2a | 8.627 | <0.001 | 1.092 | <0.001 | 1.484 | <0.001 | 1113.99 | 0.3816 | 11.89 % | 15.80 % |
| =2 | (6.519, 10.735) | (0.558, 1.625) | (0.924, 2.044) | (6.74 %, 17.03 %) | (10.48 %, 21.12 %) | |||||
| gologit2a =3 | 9.652 | <0.001 | 0.964 | 0.073 | 0.387 | 0.507 | 9.50 % | 3.93 % | ||
| (6.915, 12.388) | (−0.091, 2.019) | (−0.756, 1.529) | (1.29 %, 17.72 %) | (−6.76 %, 14.61 %) | ||||||
| slogita | 18.523 | <0.001 | 1.867 | <0.001 | 2.148 | <0.001 | 1061.13 | 0.3594 | 9.59 % | 10.95 % |
| (15.277,21.769) | (0.997, 2.738) | (1.275, 3.022) | (5.80 %, 13.38 %) | (7.23 %, 14.67 %) | ||||||
| mixedb | 1.424 | <0.001 | 0.158 | <0.001 | 0.175 | <0.001 | 1119.97 | 0.1857 | 10.53 % | 11.57 % |
| (1.218, 1.630) | (0.085, 0.231) | (0.102, 0.248) | (6.47 %, 14.59 %) | (7.58 %, 15.55 %) | ||||||
| meologitb | 9.179 | <0.001 | 0.967 | <0.001 | 1.085 | <0.001 | 1123.66 | 0.1853 | 10.00 % | 11.15 % |
| (7.031, 11.328) | (0.468, 1.467) | (0.578, 1.592) | (6.03 %, 13.98 %) | (7.25 %, 15.05 %) | ||||||
95 % confidence limits of each estimate given in parentheses
aregression model with fixed effects only
bregression model with fixed and random effects
Parameter estimation of id2 versus id4
| Model | GWscore | GQscore | BGscore | |||
|---|---|---|---|---|---|---|
| Est. |
| Est. |
| Est. |
| |
| regressa | −0.050 | 0.199 | −0.017 | 0.641 | −0.054 | 0.141 |
| (−0.126, 0.026) | (−0.087, 0.054) | (−0.126, 0.018) | ||||
| ologita | −0.322 | 0.164 | −0.13 | 0.603 | −0.374 | 0.127 |
| (−0.775, 0.131) | (−0.621, 0.361) | (−0.854, 0.107) | ||||
| gologit2a | −0.215 | 0.488 | −0.393 | 0.185 | −0.596 | 0.046 |
| =2 | (−0.823, 0.392) | (−0.975, 0.189) | (−1.182, −0.010) | |||
| gologit2a | −0.472 | 0.182 | 0.629 | 0.228 | 0.104 | 0.82 |
| =3 | (−1.166, 0.221) | (−0.394, 1.653) | (−0.788, 0.996) | |||
| slogita | −0.592 | 0.194 | −0.408 | 0.281 | −0.743 | 0.052 |
| (−1.485, 0.301) | (−1.150, 0.334) | (−1.491, 0.005) | ||||
| mixedb | −0.050 | 0.176 | −0.017 | 0.640 | −0.054 | 0.14 |
| (−0.122, .022) | (−0.087, 0.053) | (−0.126, 0.018) | ||||
| meologitb | −0.3217 | 0.164 | −0.126 | 0.598 | −0.336 | 0.152 |
| (−0.775, 0.131) | (−0.597, 0.344) | (−0.794, 0.123) | ||||
95 % confidence limits given in parentheses
aregression model with fixed effects only
bregression model with fixed and random effects
Estimated parameters, Goodness-of-fit statistics and dose reduction of GWrank
| Model | Coefficient | Goodness-of-fit | Dose Reduction | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| logCTDI | id2 | id4 | AIC | Pseudo R2 | id2 | id4 | ||||
| Est. | P-value | Est. | P-value | Est. | P-value | |||||
| regressa | 4.482 | <0.001 | 0.850 | <0.001 | 0.696 | <0.001 | - | 0.0959 | 17.27 % | 14.38 % |
| (3.981, 4.983) | (0.673, 1.027) | (0.518, 0.873) | (14.44 %, 20.11 %) | (11.44 %, 17.32 %) | ||||||
| ologita | 9.247 | <0.001 | 1.780 | <0.001 | 1.531 | <0.001 | 2462.68 | 0.1138 | 17.51 % | 15.26 % |
| (8.126, 10.368) | (1.428, 2.132) | (1.168, 1.894) | (14.99 %, 20.02 %) | (12.51 %, 18.01 %) | ||||||
| rologita | 5.537 | <0.001 | 1.232 | <0.001 | 0.932 | <0.001 | 1303.66 | 0.1493 | 19.95 % | 15.49 % |
| (4.734, 6.340) | (0.969, 1.495) | (0.666, 1.197) | (17.06 %, 22.84 %) | (12.24 %, 18.74 %) | ||||||
| mixedb | 4.482 | <0.001 | 0.850 | <0.001 | 0.696 | <0.001 | 2670.66 | 0.0000 | 17.27 % | 14.38 % |
| (3.995, 4.970) | (0.677, 1.023) | (0.523, 0.869) | (14.51 %, 20.04 %) | (11.51 %, 17.24 %) | ||||||
| meologitb | 9.267 | <0.001 | 1.751 | <0.001 | 1.549 | <0.001 | 2452.89 | 0.0320 | 17.22 % | 15.40 % |
| (8.991, 9.543) | (1.416, 2.086) | (1.214, 1.885) | (14.36 %, 20.07 %) | (12.43 %, 18.36 %) | ||||||
95 % confidence limits of each estimate given in parentheses
aregression model with fixed effects only
bregression model with fixed and random effects
Estimated parameters, Goodness-of-fit statistics and dose reduction of BGrank
| Model | Coefficient | Goodness-of-fit | Dose Reduction | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| logCTDI | id2 | id4 | AIC | Pseudo R2 | id2 | id4 | ||||
| Est. | P-value | Est. | P-value | Est. | P-value | |||||
| regressa | −4.812 | <0.001 | −0.863 | <0.001 | −0.683 | <0.001 | - | 0.1141 | 16.41 % | 13.24 % |
| (−5.299, −4.324) | (−1.035, −0.690) | (−0.856, −0.511) | (13.82 %, 19.00 %) | (10.53 %, 15.95 %) | ||||||
| ologita | −9.793 | <0.001 | −1.734 | <0.001 | −1.424 | <0.001 | 2420.57 | 0.1297 | 16.23 % | 13.53 % |
| (−10.916, −8.671) | (−2.081, −1.387) | (−1.780, −1.067) | (13.80 %, 18.65 %) | (10.86 %, 16.20 %) | ||||||
| rologita | −5.344 | <0.001 | −0.881 | <0.001 | −0.836 | <0.001 | 1308.64 | 0.1461 | 15.20 % | 14.48 % |
| (−6.116, −4.571) | (−1.117. −0.645) | (−1.081, −0.592) | (12.01 %, 18.40 %) | (11.10 %, 17.87 %) | ||||||
| mixedb | −4.812 | <0.001 | −0.862 | <0.001 | −0.683 | <0.001 | 2617. 17 | 0.000 | 16.41 % | 13.24 % |
| (−5.286, −4.337) | (−1.030, −0.694) | (−0.851, −0.515) | (13.88 %, 18.94 %) | (10.60 %, 15.88 %) | ||||||
| meologitb | −10.460 | <0.001 | −1.861 | <0.001 | −1.545 | <0.001 | 2355.74 | 0.0086 | 16.30 % | 13.73 % |
| (−10.633, −10.288) | (−2.144, −1.579) | (−1.846, −1.245) | (14.01 %, 18.59 %) | (11.24 %, 16.23 %) | ||||||
95 % confidence limits of each estimate given in parentheses
aregression model with fixed effects only
bregression model with fixed and random effects
Estimated parameters, Goodness-of-fit statistics and dose reduction of GQrank
| Model | Coefficient | Goodness-of-fit | Dose Reduction | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| logCTDI | id2 | id4 | AIC | Pseudo R2 | id2 | id4 | ||||
| Est. | P-value | Est. | P-value | Est. | P-value | |||||
| regressa | −4.671 | <0.001 | −0.817 | <0.001 | −0.463 | <0.001 | - | 0.1134 | 16.04 % | 9.43 % |
| (−5.158, −4.183) | (−.989, −.644) | (−0.635, −0.290) | (13.36 %, 18.73 %) | (6.44 %, 12.42 %) | ||||||
| ologita | −9.433 | <0.001 | −1.691 | <0.001 | −1.033 | <0.001 | 2427.97 | 0.1269 | 16.41 % | 10.37 % |
| (−10.550, −8.317) | (−2.039, −1.343) | (−1.395, −0.672) | (13.93 %, 18.88 %) | (7.39 %, 13.36 %) | ||||||
| rologita | −4.766 | <0.001 | −0.709 | <0.001 | −0.576 | <0.001 | 1337.79 | 0.1270 | 13.81 % | 11.38 % |
| (−5.516, −4.015) | (−0.940, −0.477) | (−0.823, −0.328) | (10.23 %, 17.40 %) | (7.35 %, 15.41 %) | ||||||
| mixedb | −4.671 | <0.001 | −0.8167 | <0.001 | −0.4625 | <0.001 | 2619.45 | 0.0000 | 16.04 % | 9.43 % |
| (−5.145, −4.196) | (−0.985, −0.648) | (−0.631, −0.294) | (13.42 %, 18.66 %) | (6.51 %, 12.34 %) | ||||||
| meologitb | −9.380 | <0.001 | −1.680 | <0.001 | −1.027 | <0.001 | 2367.96 | 0.0105 | 16.40 % | 13.37 % |
| (−9.506, −9.255) | (−1.956, −1.405) | (−1.331, −0.723) | (13.91 %, 18.89 %) | (7.45 %, 13.29 %) | ||||||
95 % confidence limits of each estimate given in parentheses
aregression model with fixed effects only
bregression model with fixed and random effects